Assessment of Biological Parameters that (Influence) Affect the Quality of Life in a Group of Patients with Metabolic Syndrome

1. Zhijun Tan, Ying Liang, Siming Liu, Wenjun Cao, Haibo Tu, Lingxia Guo, and Yongyong Xu. Health-Related Quality of Life as Measured with EQ-5D among Populations wit hand without Specific Chronic Conditions: A Population-Based Survey in Shaanxi Province, ChinaPLoS One. 2013;8(7):e65958. Published online 2013 Jul 2. doi: 10.1371/journal.pone.0065958 PMCID: PMC3699581.10.1371/journal.pone.0065958369958123843948 Search in Google Scholar

2. Wille N, Badia X, Bonsel G, Burström K, Cavrini G, Devlin N, Egmar AC, Greiner W, Gusi N, Herdman M, Jelsma J, Kind P, Scalone L, Ravens-Sieberer U. Development of the EQ-5D-Y: a child-friendly version of the EQ-5D. Qual Life Res. 2010;19(6):875-86. doi: 10.1007/s11136-010-9648-y. PMID: 20405245; PMCID: PMC2892611.10.1007/s11136-010-9648-y289261120405245 Search in Google Scholar

3. EuroQol Research Foundation. EQ-5D-Y User Guide, Version 2.0, 2020. Available from: https://euroqol.org/publications/user-guides/. Accessed on 12.05.2021. Search in Google Scholar

4. https://euroqol.org/eq-5d-instruments/eq-5d-5l-about/valuation-standard-value-sets/ Accessed on 07.06.2021. Search in Google Scholar

5. Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, Swinburn P, Busschbach J. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2013;22(7):1717-27. doi: 10.1007/s11136-012-0322-4. PMID: 23184421; PMCID: PMC3764313.10.1007/s11136-012-0322-4376431323184421 Search in Google Scholar

6. van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, Lloyd A, Scalone L, Kind P, Pickard AS. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15(5):708-15. doi: 10.1016/j.jval.2012.02.008. PMID: 22867780.10.1016/j.jval.2012.02.00822867780 Search in Google Scholar

7. Dyer MT, Goldsmith KA, Sharples LS, Buxton MJ. A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes. 2010;8:13. doi:10.1186/1477-7525-8-13. PMID: 20109189; PMCID: PMC2824714.10.1186/1477-7525-8-13282471420109189 Search in Google Scholar

8. Batóg P, Rencz F, Péntek M, Gulácsi L, Filipiak KJ, Prevolnik Rupel V, Simon J, Brodszky V, Baji P, Závada J, Petrova G, Rotar A, Golicki D. EQ-5D studies in cardiovascular diseases in eight Central and Eastern European countries: a systematic review of the literature. Kardiol Pol. 2018;76(5):860-870. doi: 10.5603/KP.a2018.0033. PMID: 29350378.10.5603/KP.a2018.003329350378 Search in Google Scholar

9. Golicki D, Dudzińska M, Zwolak A, Tarach JS. Quality of life in patients with type 2 diabetes in Poland - comparison with the general population using the EQ-5D questionnaire, Adv Clin Exp Med, doi: 10.17219/acem/38137.10.17219/acem/3813725923098 Search in Google Scholar

10. Bulamu NB, Kaambwa B, Ratcliffe J. A systematic review of instruments for measuring outcomes in economic evaluation within aged care. Health Qual Life Outcomes. 2015 Nov;13:179. DOI: 10.1186/s12955-015-0372-8. PMID: 26553129; PMCID: PMC4640110.10.1186/s12955-015-0372-8464011026553129 Search in Google Scholar

11. Yang Y, Brazier J, Longworth L. EQ-5D in skin conditions: an assessment of validity and responsiveness. Eur J Health Econ. 2015;16(9):927-939. doi:10.1007/s10198-014-0638-9. PMID: 25358263; PMCID: PMC4646948.10.1007/s10198-014-0638-9464694825358263 Search in Google Scholar

12. Schwenkglenks M, Matter-Walstra K. Is the EQ-5D suitable for use in oncology? An overview of the literature and recent developments. Expert Rev Pharmacoecon Outcomes Res. 2016;16(2):207-219. doi:10.1586/14737167.2016.1146594. PMID: 26808097.10.1586/14737167.2016.114659426808097 Search in Google Scholar

13. Shim J, Hamilton DF. Comparative responsiveness of the PROMIS-10 Global Health and EQ-5D questionnaires in patients undergoing total knee arthroplasty. Bone Joint J. 2019;101-B(7):832-837. doi:10.1302/0301-620X.101B7.BJJ-2018-1543.R1. PMID: 31256677; PMCID: PMC6616061.10.1302/0301-620X.101B7.BJJ-2018-1543.R1661606131256677 Search in Google Scholar

14. Szende A, Janssen B, Cabases J, editors. Self-Reported Population Health: An International Perspective based on EQ-5D. Dordrecht (NL): Springer; 2014. DOI: 10.1007/978-94-007-7596-1. PMID: 29787044.10.1007/978-94-007-7596-129787044 Search in Google Scholar

15. Shiroiwa T, Fukuda T, Ikeda S, Igarashi A, Noto S, Saito S, Shimozuma K. Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D. Qual Life Res. 2016;25(3):707-19. doi: 10.1007/s11136-015-1108-2. PMID: 26303761; PMCID: PMC4759213.10.1007/s11136-015-1108-2475921326303761 Search in Google Scholar

16. Janssen MF, Lubetkin EI, Sekhobo JP, Pickard AS: The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus. Diabet Med. 2011;28:395-413.10.1111/j.1464-5491.2010.03136.x21392061 Search in Google Scholar

17. eq5d: Methods for Analysing EQ-5D Data and Calculating EQ-5D Index Scores https://rdrr.io/cran/eq5d/ Search in Google Scholar

18. Hayes AJ, Clarke PM, Glasziou PG, Simes RJ, Drury PL, Keech AC: Can self-rated health scores be used for risk prediction in patients with type 2 diabetes? Diabetes Care. 2008;31:795-797.10.2337/dc07-139118184900 Search in Google Scholar

19. Bagust A, Beale S. Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data.Health Econ. 2005;14:217-230.10.1002/hec.91015386666 Search in Google Scholar

20. Clarke P, Gray A, Holman R. Estimating utility values for health states of type 2 diabetic patients using the EQ-5D(UKPDS 62). Med Decis Making. 2002;22:340-349.10.1177/027298902400448902 Search in Google Scholar

21. Holmes J, McGill S, Kind P, Bottomley J, Gillam S, Murphy M. Health-related quality of life in type 2 diabetes (TARDIS-2). Value Health. 2000;3:47-51.10.1046/j.1524-4733.2000.36028.x16464209 Search in Google Scholar

22. Redekop WK, Koopmanschap MA, Stolk RP, Rutten GE, Wolffenbuttel BH, Niessen LW: Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care. 2002;25:458-463.10.2337/diacare.25.3.45811874930 Search in Google Scholar

23. Solli O, Stavem K, Kristiansen IS. Health-related quality of life in diabetes: The associations of complications with EQ-5D scores. Health and Quality of Life Outcomes. 2010;8:18.10.1186/1477-7525-8-18282953120132542 Search in Google Scholar

24. Holmes J, McGill S, Kind P, Bottomley J, Gillam S, et al. Health-related Quality of Life in Type 2 Diabetes (T2ARDIS-2). Value in Health 3. 2000;S47–S51.10.1046/j.1524-4733.2000.36028.x16464209 Search in Google Scholar

25. Lee WJ, Song KH, Noh JH, Choi YJ, Jo MW. (2012) Health-Related Quality of Life Using the EuroQol 5D Questionnaire in Korean Patients with Type 2 Diabetes. Journal of Korean Medical Science. 2012;27:255-260.10.3346/jkms.2012.27.3.255328677122379335 Search in Google Scholar

26. Redekop WK, Rutten G, Koopmanschap MA, Wolffenbuttel BHR, Stolk RP, et al. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care. 2002;25:458-463.10.2337/diacare.25.3.45811874930 Search in Google Scholar

27. Peyrot M, Rubin RR. Persistence of depressive symptoms in diabetic adults. Diabetes Care. 1999;22:448-452.10.2337/diacare.22.3.44810097927 Search in Google Scholar